“Let food be thy medicine and medicine be thy food,” the ancient Greek physician Hippocrates proclaimed. Almost 2,500 years later, biologists and geneticists around the world have come to the conclusion that he was right. With antibiotics in...
The saying goes that if you want to stay friends with people, you shouldn’t talk about religion or politics. In the 21 st century, perhaps another subject should be added to the list of taboo subjects in polite company: genomics. One genomics debate...
The team behind Russia's biggest genome project to date, Genome Russia, is holding a “bake off” of genome sequencing centres to determine which centre would handle the crucial task most efficiently. There's just one problem: if the winner...
National genome projects that study the gene pool of a specific country can not only reveal much about a country’s history and its inhabitants’ roots, they can also bring about advances in medical treatment. But while some countries have poured...
Skolkovo has begun accepting applications from startup companies in the agriculture business and expects its first residents by the end of the year, opening up new avenues of research that experts say are of critical importance for biotech in Russian and beyond...
Seventeen innovations received recognition at the Minsk stage of the Startup Tour this week, with four projects winning a place in the pitch sessions at Startup Village in Moscow this summer. The winners of the Belarus pitch sessions. Photo: sk.ru ...
The concept of omics may still leave most people baffled, but for science communities, this hugely promising approach to biolomedical research is already 25 years old and ignorance could be costly. Skolkovo, for its part, is taking no chances. The Hypercube...
Skolkovo on Wednesday unveiled its inaugural almanac, a major effort to bring smart discussion on the latest biotechnology advances to a broad audience in Russia. Issue One discusses the field of so-called omics – a collection of biology study areas...
The recent appointment of Yuri Nikolsky at the Skolkovo Foundation’s biomed technologies cluster appears to be bearing fruit already: The pharmaceuticals guru says several new companies are about to join the group’s 200-strong residents. Nikolsky...